Infliximab (N=8)
Etanercept (N=14)
Adalimumab (N=2)
Exposure-rate (patient-year)
19,2
62,1
1,98
Exposure-adjusted rates of adverse events (patient-year)
1,25
0,05
0,5
N = number of patients.